» Articles » PMID: 34150911

A Comprehensive Review on Global Contributions and Recognition of Pharmacy Professionals Amidst COVID-19 Pandemic: Moving from Present to Future

Overview
Specialty Pharmacology
Date 2021 Jun 21
PMID 34150911
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: COVID-19, a respiratory tract infection caused by SARS-CoV-2, is a burning question worldwide as it gives rise to a pandemic situation. No specific medications are still recommended for COVID-19; however, healthcare support is crucial for ameliorating the disease condition. Pharmacists are the frontline fighters who are responsible for providing healthcare support to the COVID-19 infected patients around the world. This review endeavored to briefly rationalize the contributions of several pharmacy professionals in diverse fields along with their collaborative efforts and dedication regarding their limitations during the COVID-19 situation and view the prospects of pharmaceutical care services in the post-pandemic period.

Main Body Of The Abstract: Online databases were utilized to search for scholarly articles and organizational websites, to sum up the information about the contemporary and expanded role of pharmacists. Key articles were retrieved from Google Scholar, PubMed, and Science Direct databases using terms: "COVID-19," "novel coronavirus," "community," "industrial," "hospital," "clinical," "recognition," "obstacles," "collaboration," "SARS-CoV-2," "healthcare," and "outbreak" in combination with "pharmacist." The articles were included from the inception of the pandemic to January 25, 2021. The current review found pharmacist's global contributions and involvements with other professionals to provide healthcare services amidst COVID-19. This included testing of suspects, providing medical information, psycho-social support, debunking myths, mitigating drug shortage events, telemedicine, e-prescription, infection control, and controlling the drug supply chain. In many countries, pharmacists' activities were much appreciated but in some countries, they were not properly acknowledged for their contributions amidst COVID-19 outbreak. They played additional roles such as participating in the antimicrobial stewardship team, improving value-added services, conducting clinical data analysis to suppress the outspread of the SARS-CoV-2.

Short Conclusion: During the COVID-19 pandemic while the whole world is fighting against an invisible virus, the pharmacists are the earnest hero to serve their responsibilities along with additional activities. They need to be prepared and collaborate with other healthcare professionals further to meet the challenges of post-pandemic circumstances.

Citing Articles

Changes in provision of extended community pharmacy services in Aotearoa New Zealand, 2018 to 2022.

Officer T, McDonald J, Jeffreys M, Cumming J, Russell L, McKinlay E BMC Health Serv Res. 2024; 24(1):1571.

PMID: 39696269 PMC: 11653777. DOI: 10.1186/s12913-024-11948-3.


The influence of COVID-19 pandemic on the mental health of pharmacists as frontline health care providers in Nepal.

Adhikari S, Kasaju S, Langkulsen U Heliyon. 2024; 10(7):e29132.

PMID: 38601518 PMC: 11004875. DOI: 10.1016/j.heliyon.2024.e29132.


Evaluation of knowledge, experiences, and fear toward prescribing and dispensing corticosteroids among Egyptian healthcare professionals: A cross-sectional study.

Barakat M, Mansour N, Elnaem M, Thiab S, Farha R, Sallam M Saudi Pharm J. 2023; 31(10):101777.

PMID: 37771957 PMC: 10523270. DOI: 10.1016/j.jsps.2023.101777.


Antimicrobial Dispensing Practices during COVID-19 and the Implications for Pakistan.

Gul B, Sana M, Saleem A, Ul Mustafa Z, Salman M, Khan Y Antibiotics (Basel). 2023; 12(6).

PMID: 37370337 PMC: 10294926. DOI: 10.3390/antibiotics12061018.


Knowledge of Community Pharmacists in Saudi Arabia Regarding Human Monkeypox, Its Management, Prevention, and Vaccination: Findings and Implications.

Alrasheedy A, Aldawsari A, Alqasir M, Alsawyan O, Alalwan O, Alwaker S Vaccines (Basel). 2023; 11(4).

PMID: 37112790 PMC: 10143221. DOI: 10.3390/vaccines11040878.


References
1.
Le T, Andreadakis Z, Kumar A, Roman R, Tollefsen S, Saville M . The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020; 19(5):305-306. DOI: 10.1038/d41573-020-00073-5. View

2.
Merks P, Jakubowska M, Drelich E, Swieczkowski D, Bogusz J, Bilmin K . The legal extension of the role of pharmacists in light of the COVID-19 global pandemic. Res Social Adm Pharm. 2020; 17(1):1807-1812. PMC: 7289723. DOI: 10.1016/j.sapharm.2020.05.033. View

3.
Langford B, So M, Raybardhan S, Leung V, Westwood D, MacFadden D . Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020; 26(12):1622-1629. PMC: 7832079. DOI: 10.1016/j.cmi.2020.07.016. View

4.
Amariles P, Ledezma-Morales M, Salazar-Ospina A, Hincapie-Garcia J . How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal. Res Social Adm Pharm. 2020; 17(1):1988-1989. PMC: 7156146. DOI: 10.1016/j.sapharm.2020.03.007. View

5.
Khan Z, Muhammad K, Ahmed A, Rahman H . Coronavirus outbreaks: prevention and management recommendations. Drugs Ther Perspect. 2020; 36(5):215-217. PMC: 7095077. DOI: 10.1007/s40267-020-00717-x. View